UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Results of the Patient-Related Outcomes of Mechanical lead Extraction Techniques (PROMET) study: a multicentre retrospective study on advanced mechanical lead extraction techniques

Europace (London, England), 2020-07, Vol.22 (7), p.1103-1110

2020

Volltextzugriff (PDF)

Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

Europace (London, England), 2017-06, Vol.19 (6), p.891-911

2017

Volltextzugriff (PDF)

The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events

Europace (London, England), 2020-02, Vol.22 (2), p.195-204

2020

Volltextzugriff (PDF)

Clinical performance of a new bidirectional rotational mechanical lead extraction sheath

Europace (London, England), 2016-02, Vol.18 (2), p.253-256

2016

Volltextzugriff (PDF)

Dose adjustment based on the plasma level measurement used anti-FXa chromogenic assay on the use of non-vitamin K antagonist oral anticoagulants (NOACs) improved the overall benefit of NOACs dosing in patients with atrial fibrillation: Authors’ reply

Europace (London, England), 2021-10, Vol.23 (10), p.1686-1687

2021

Volltextzugriff (PDF)

Non-vitamin K oral anticoagulants in 'valvular' atrial fibrillation: a call for action

Europace (London, England), 2016-01, Vol.18 (1), p.1-3

2016

Volltextzugriff (PDF)

2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: comment

Europace (London, England), 2021-10, Vol.23 (10), p.1685-1685

2021

Volltextzugriff (PDF)

2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Europace (London, England), 2021-10, Vol.23 (10), p.1612-1676

2021

Volltextzugriff (PDF)

2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: comment—Authors’ reply

Europace (London, England), 2021-10, Vol.23 (10), p.1685-1686

2021

Volltextzugriff (PDF)

2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Hea

Europace (London, England), 2019-02, Vol.21 (2), p.192-193

2019

Volltextzugriff (PDF)

Magnetic field interaction between a left ventricular assist device controller and a cardiac resynchronization therapy-defibrillator

Europace (London, England), 2015-11, Vol.17 (11), p.1719-1719

2015

Volltextzugriff (PDF)

Dose adjustment based on the plasma level measurement used anti-FXa chromogenic assay on the use of non-vitamin K antagonist oral anticoagulants (NOACs) improved the overall benefit of NOACs dosing in patients with atrial fibrillation

Europace (London, England), 2021-10, Vol.23 (10), p.1686-1686

2021

Volltextzugriff (PDF)

Leadless pacemaker implantation via the internal jugular vein

Europace (London, England), 2024-08, Vol.26 (8)

2024

Volltextzugriff (PDF)

Idarucizumab in the ‘real world’: possibilities and limitations

Europace (London, England), 2019-03, Vol.21 (3), p.359-360

2019

Volltextzugriff (PDF)

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary

Europace (London, England), 2018-08, Vol.20 (8), p.1231-1242

2018

Volltextzugriff (PDF)

Left femoral venous access for leadless pacemaker implantation: patient characteristics and outcomes

Europace (London, England), 2021-09, Vol.23 (9), p.1456-1461

2021

Volltextzugriff (PDF)

Right ventricular only pacing for cardiac resynchronization therapy

Europace (London, England), 2022-01, Vol.24 (1), p.70-71

2022

Volltextzugriff (PDF)

Development and validation of a risk score for predicting pericardial effusion in patients undergoing leadless pacemaker implantation: experience with the Micra transcatheter pacemaker

Europace (London, England), 2022-07, Vol.24 (7), p.1119-1126

2022

Volltextzugriff (PDF)

Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care

Europace (London, England), 2021-08, Vol.23 (8), p.1324-1342

2021

Volltextzugriff (PDF)

Insertion of miniaturized cardiac monitors outside the catheter operating room: experience and practical advice

Europace (London, England), 2017-10, Vol.19 (10), p.1624-1629

2017

Volltextzugriff (PDF)

EHRA White Paper: knowledge gaps in arrhythmia management—status 2019

Europace (London, England), 2019-07, Vol.21 (7), p.993-994

2019

Volltextzugriff (PDF)

Optimized Implementation of cardiac resynchronization therapy - a call for action for referral and optimization of care

Europace (London, England), 2023-06

2023

Volltextzugriff (PDF)

Corrigendum to: 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

Europace (London, England), 2021-10, Vol.23 (10), p.1676-1676

2021

Volltextzugriff (PDF)

Transvenous lead extractions: comparison of laser vs. mechanical approach

Europace (London, England), 2013-11, Vol.15 (11), p.1636-1641

2013

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals 2020 Medicine

Zeitschrift / SerieEuropace

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(32)

Sprache

Erscheinungsjahr

n.n

Thema

Cardiac & Cardiovascular Systems
(25)
Cardiovascular System & Cardiology
(25)
Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Humans
(11)
Treatment Outcome
(6)
Female
(5)
Medicin Och Hälsovetenskap
(5)
Aged
(4)
Atrial Fibrillation
(4)
Clinical Research
(4)
Male
(4)
Pacemaker
(4)
Risk Factors
(4)
Administration, Oral
(3)
Adult
(3)
Anticoagulation
(3)
Atrial Fibrillation - Drug Therapy
(3)
Cardiac Resynchronization Therapy
(3)
Cardiac Resynchronization Therapy Devices
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Oxford journals
(32)
EZB Electronic Journals Library
(32)
Ovid SocietyJournals and Single Titles
(29)
Ingenta
(29)
MEDLINE
(12)
IngentaConnect Journals
(8)

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Ep Europace
(4)

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Results of the Patient-Related Outcomes of Mechanical lead Extraction Techniques (PROMET) study: a multicentre retrospective study on advanced mechanical lead extraction techniques

The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events

Clinical performance of a new bidirectional rotational mechanical lead extraction sheath

Dose adjustment based on the plasma level measurement used anti-FXa chromogenic assay on the use of non-vitamin K antagonist oral anticoagulants (NOACs) improved the overall benefit of NOACs dosing in patients with atrial fibrillation: Authors’ reply

Non-vitamin K oral anticoagulants in 'valvular' atrial fibrillation: a call for action

2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: comment

2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: comment—Authors’ reply

Magnetic field interaction between a left ventricular assist device controller and a cardiac resynchronization therapy-defibrillator

Dose adjustment based on the plasma level measurement used anti-FXa chromogenic assay on the use of non-vitamin K antagonist oral anticoagulants (NOACs) improved the overall benefit of NOACs dosing in patients with atrial fibrillation

Leadless pacemaker implantation via the internal jugular vein

Idarucizumab in the ‘real world’: possibilities and limitations

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary

Left femoral venous access for leadless pacemaker implantation: patient characteristics and outcomes

Right ventricular only pacing for cardiac resynchronization therapy

Development and validation of a risk score for predicting pericardial effusion in patients undergoing leadless pacemaker implantation: experience with the Micra transcatheter pacemaker

Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care

Insertion of miniaturized cardiac monitors outside the catheter operating room: experience and practical advice

EHRA White Paper: knowledge gaps in arrhythmia management—status 2019

Optimized Implementation of cardiac resynchronization therapy - a call for action for referral and optimization of care

Corrigendum to: 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

Transvenous lead extractions: comparison of laser vs. mechanical approach

Withdrawn as duplicate: Optimized Implementation of cardiac resynchronization therapy – a call for action for referral and optimization of care

Aktive Filter

Suchergebnisse filtern